January 11, 2018 / 12:41 PM / a year ago

BRIEF-Forty Seven Inc Says Announced Deal With Genentech To Collaborate On Novel Immuno-Oncology Combination For Leukemia, Bladder Cancer

Jan 11 (Reuters) - Roche Holding Ag:

* FORTY SEVEN INC SAYS ANNOUNCED DEAL WITH GENENTECH TO COLLABORATE ON NOVEL IMMUNO-ONCOLOGY COMBINATION FOR LEUKEMIA, BLADDER CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below